MedCap AB (publ)

MedCap AB (publ) EBIT per Share

The EBIT per Share of MedCap AB (publ) (MCAP.ST) as of Nov 22, 2026 is 20.01 SEK. In the previous year, EBIT per Share was 18.32 SEK — a change of 9.20% (higher).

EBIT per Share

20.01SEK

YoY

9.20%

Last updated:

EBIT per Share of MedCap AB (publ) is 2025 20.01 SEK. EBIT per Share of MedCap AB (publ) was 2024 18.32 SEK. It decreases by 9.20% higher compared to the previous year.

The MedCap AB (publ) EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2023
15.30 SEK
Jan 1, 2024
18.32 SEK
Jan 1, 2025
20.01 SEK
Jan 1, 2026 (e)
28.48 SEK
Jan 1, 2027 (e)
36.27 SEK
Jan 1, 2028 (e)
35.40 SEK
Jan 1, 2029 (e)
40.42 SEK
Jan 1, 2030 (e)
42.94 SEK
The MedCap AB (publ) EBIT per Share history
YEAREBIT per ShareYoY
est42.94SEK+6.25%
est40.42SEK+14.16%
est35.40SEK-2.37%
est36.27SEK+27.35%
est28.48SEK+42.33%
20.01SEK+9.20%
18.32SEK+19.73%
15.30SEK+32.58%
11.54SEK+34.52%
8.58SEK+42.48%
6.02SEK-2.64%
6.19SEK-2,080.95%
-0.31SEK+132.47%
-0.13SEK-54.83%
-0.30SEK-112.39%
2.40SEK+193.92%
0.82SEK-67.98%
2.55SEK+50.77%
1.69SEK+5.40%
1.60SEK-29.08%
2.26SEK+109.39%
1.08SEK-5,064.43%
-0.02SEK-93.39%
-0.33SEK+1,053.06%
-0.03SEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

MedCap AB (publ) Stock analysis

What does MedCap AB (publ) do? MedCap AB (publ) is a Swedish company specializing in the development and marketing of medical products. The company was founded in 2006 by a group of experts in the medical industry. MedCap's business model is focused on developing and marketing innovative medical products. The company has two main business areas: Medical Devices and Diagnostics. In the Medical Devices area, MedCap develops products for various medical applications, including respiratory diseases, pain therapy, and wound care. In the Diagnostics area, the company offers diagnostic tests for various diseases, including infectious diseases and cancer. MedCap aims to improve medical care through innovative products. The company has introduced a range of groundbreaking products that offer higher effectiveness and more convenient use for patients. An example of a MedCap product is the Aeroneb® Pro. This is an advanced nebulizer device used for the treatment of respiratory diseases such as asthma, COPD, and cystic fibrosis. According to MedCap, the Aeroneb® Pro is the most effective nebulizer device of its kind, offering higher medication absorption through the lungs than other nebulizer devices. Another MedCap product is the ClipOn® Pain Relief. This is a portable pain reliever used to alleviate pain from various diseases such as arthritis and back pain. According to MedCap, the ClipOn® Pain Relief is a fast and safe way to relieve pain and improve patients' quality of life. In the Diagnostics area, MedCap offers a range of diagnostic tests for infectious diseases, including HIV, hepatitis, and tuberculosis. An example of a MedCap diagnostic test is the Diagnostics Quick Test (DQT), a rapid test for HIV detection. According to MedCap, the DQT is the fastest HIV test on the market, providing results in just 15 minutes. MedCap has also focused on the field of personalized medicine. The company has developed a platform called Confero that enables doctors to offer personalized medicine to their patients. Confero utilizes artificial intelligence and machine learning to provide accurate diagnosis and treatment for each patient. Overall, MedCap has established itself as a leading company in the medical industry, offering innovative products and services for medical care. The company has a strong presence in Europe and is also expanding into other parts of the world. MedCap aims to improve medical care through its products and services, making a positive impact on the lives of patients. MedCap AB (publ) is one of the most popular companies on Eulerpool.

Frequently Asked Questions about MedCap AB (publ) stock

EBIT per Share of MedCap AB (publ) is 20.01 SEK in 2025.

EBIT per Share of MedCap AB (publ) changed from 18.32 SEK to 20.01 SEK, representing a 9.20% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share MedCap AB (publ) since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — MedCap AB (publ)

All Key Metrics — MedCap AB (publ)